Pharmaceutical
| Fri 18 Apr 2025
Munich, April 18 -- Hitgen Inc and Sichuan Kelun-Biotech Biopharmaceutical have applied European patent for compound and use thereof in preparation of BCL-XL inhibitor. Liu Chuan, Liu Jinming, Dou Dengfeng, Liu Qian, Xia Shuai, Tai Zhengfu, Zhang Wei, Yang Xiaojiao, Cai Longying, Song Hongmei, Li Jin and Ge Junyou developed it.
..